|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH PROVIDED (USED IN) BY OPERTING ACTIVITIES | |||||
| Net earnings | |||||
| Adjustments for items not involving cash: | |||||
| Amortization | |||||
| Reversal of impairment (Note 10) | |||||
| Inventory net realizable value adjustment | |||||
| Foreign exchange loss (gain) | |||||
| Current income tax expense | |||||
| Deferred income tax expense | |||||
| Share-based compensation (Note 19(d)) | |||||
| Finance (income) expense | |||||
| Loss on commodity derivatives | |||||
| Gain on sale of assets (Note 7) | |||||
| Deferred revenue recognized (Note 14) | |||||
| Settlement of Argonaut legacy gold hedges (Note 13) | |||||
| Proceeds from gold sale prepayment (Note 14) | |||||
| Other items (Note 23) | |||||
| Changes in working capital and taxes paid (Note 23) | |||||
| Cash flows from (used in) operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Mineral property, plant and equipment | |||||
| Proceeds from sale of Esperanza Project (note 8) | |||||
| Interest capitalized to mineral property, plant and equipment | |||||
| Proceeds from disposition of equity securities | |||||
| Investment in equity securities | |||||
| Investment in Argonaut, net of cash acquired (Note 6) | |||||
| Proceeds from sale of assets, net of transaction costs (Note 7) | |||||
| Transaction costs arising on asset dispositions and acquisitions (Note 5, Note 8) | |||||
| Cash flows from (used in) investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Proceeds from draw down of credit facility | |||||
| Dividends paid (Note 19) | |||||
| Repurchase and cancellation of common shares (Note 19) | |||||
| Credit facility transaction, standby fees and interest (Note 15) | |||||
| Lease payments (Note 16) | |||||
| Proceeds from issuance of flow-through shares | |||||
| Proceeds from the exercise of options and warrants | |||||
| Repurchase and cancellation of common shares | |||||
| Cash flows from (used in) financing activities | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Increase in cash and cash equivalents | |||||
| Cash and cash equivalents - beginning of year | |||||
| CASH AND CASH EQUIVALENTS - END OF YEAR | |||||
Loading...